Cargando…
Evidence for single-dose protection by the bivalent HPV vaccine—Review of the Costa Rica HPV vaccine trial and future research studies
The Costa Rica Vaccine Trial (CVT), a phase III randomized clinical trial, provided the initial data that one dose of the HPV vaccine could provide durable protection against HPV infection. Although the study design was to administer all participants three doses of HPV or control vaccine, 20% of wom...
Autores principales: | Kreimer, Aimée R., Herrero, Rolando, Sampson, Joshua N., Porras, Carolina, Lowy, Douglas R., Schiller, John T., Schiffman, Mark, Rodriguez, Ana Cecilia, Chanock, Stephen, Jimenez, Silvia, Schussler, John, Gail, Mitchell H., Safaeian, Mahboobeh, Kemp, Troy J., Cortes, Bernal, Pinto, Ligia A., Hildesheim, Allan, Gonzalez, Paula |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054558/ https://www.ncbi.nlm.nih.gov/pubmed/29366703 http://dx.doi.org/10.1016/j.vaccine.2017.12.078 |
Ejemplares similares
-
Reduced Prevalence of Oral Human Papillomavirus (HPV) 4 Years after Bivalent HPV Vaccination in a Randomized Clinical Trial in Costa Rica
por: Herrero, Rolando, et al.
Publicado: (2013) -
Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine Trial
por: Panagiotou, Orestis A, et al.
Publicado: (2015) -
Analysis of cervical HPV infections among unvaccinated young adult women to inform vaccine strategies in this age group: the Costa Rica HPV Vaccine Trial
por: Sierra, Mónica S., et al.
Publicado: (2023) -
Proof-of-Principle Evaluation of the Efficacy of Fewer Than Three Doses of a Bivalent HPV16/18 Vaccine
por: Kreimer, Aimée R., et al.
Publicado: (2011) -
HPV16 infection decreases vaccine-induced HPV16 antibody avidity: the CVT trial
por: Tsang, Sabrina H., et al.
Publicado: (2022)